Skip to main content
. 2020 Aug 12;10:13600. doi: 10.1038/s41598-020-70627-5

Table 1.

Baseline characteristics of the 766 individuals of Tehran cardio-metabolic genetic study with 15 years follow up.

Variable* MHO MUO P-value**
Female Male Total Female Male Total Female Male Total
Participant, n (%) 169 (82) 37 (18) 206 378 (67.5) 182 (32.5) 560  < 0.001  < 0.001 ND
Age (year) 30 ± 8 27 ± 8 29 ± 8 36 ± 10 34 ± 11 35 ± 10  < 0.001 0.02  < 0.001
FPG (mg/dl) 84 ± 7 86 ± 6 85 ± 7 87 ± 11 88 ± 6 87 ± 9  < 0.001 NS  < 0.001
SBP (mmHg) 105 ± 9 108 ± 7 106 ± 8 111 ± 11 112 ± 14 111 ± 12  < 0.001 NS  < 0.001
DBP (mmHg) 71 ± 7 69 ± 8 70 ± 7 74 ± 7 73 ± 9 74 ± 8  < 0.001 NS  < 0.001
TG (mg/dl) 86 ± 32 97 ± 33 88 ± 32 110 ± 42 124 ± 57 115 ± 51  < 0.001 NS  < 0.001
HDL (mg/dl) 51 ± 11 45 ± 6 50 ± 10 47 ± 11 43 ± 8 46 ± 10  < 0.001 NS  < 0.001
WC (cm) 80 ± 7 90 ± 9 82 ± 8 86 ± 7 89 ± 7 87 ± 7  < 0.001 NS  < 0.001
BMI (kg/m2) 27 ± 2 27 ± 3 27 ± 2 28 ± 2 27 ± 2 28 ± 2  < 0.001 NS  < 0.001
HOMA-IR 1.6 ± 0.77 1.9 ± 0.8 1.7 ± 0.78 1.8 ± 1.01 1.79 ± 1.00 1.8 ± 1.00 0.04 NS NS
IR, n (%) 10 (5.9) 5 (13.5) 15 (7.3) 44 (11.6) 11 (6.0) 55 (9.8) NS NS NS
Low physical activity (METS) 28 (16.6) 4 (10.8) 32 (15.5) 75 (19.8) 37 (20.3) 112 (20) NS NS NS
Non-smoker, n (%) 161 (95.3) 30 (81) 191(92.7) 357 (94.4) 137 (75.3) 494 (92.2) NS 0.02 0.02
Menopause, n (%) 30 (17.8) ND 78 (20.6) ND NS ND ND

MHO metabolic healthy obese; MUO metabolic unhealthy obese; FPG fasting plasma glucose; SBP systolic blood pressure; DBP diastolic blood pressure; TG triglyceride; HDL high density lipoprotein; WC waist circumference; BMI body mass index; HOMA-IR homeostatic model assessment of insulin resistance; IR, insulin resistance; NS not significant at 0.05 level; ND, not done.

*Variables expressed as means ± standard deviation or number of individuals (percentages).

**P-value related to comparing MHO and MUO groups using t-test / Chi Square test for quantitative / qualitative variables, respectively.